(Q38109665)

29 August 2017

title

Update on the use of pathogen-reduced human plasma and platelet concentrates (English)

1 reference

29 August 2017

Axel Seltsam

1

1 reference

29 August 2017

Thomas H Müller

series ordinal

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

27 May 2013

1 reference

British Journal of Haematology

29 August 2017

published in

1 reference

29 August 2017

volume

162

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

442-454

1 reference

Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies

29 August 2017

cites work

1 reference

Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.

21 January 2018

1 reference

Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply

21 January 2018

1 reference

Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction

21 January 2018

1 reference

Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets.

21 January 2018

1 reference

Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States

21 January 2018

1 reference

Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients

21 January 2018

1 reference

Solvent detergent vs. fresh frozen plasma in cirrhotic patients undergoing liver transplant surgery: a prospective randomized control study

21 January 2018

1 reference

Bacterial contamination of cellular blood components: risks, sources and control

21 January 2018

1 reference

Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future

21 January 2018

1 reference

Current and emerging infectious risks of blood transfusions

21 January 2018

1 reference

An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment

21 January 2018

1 reference

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

21 January 2018

1 reference

Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period

21 January 2018

1 reference

Preclinical safety profile of plasma prepared using the INTERCEPT Blood System

21 January 2018

1 reference

Assessment of safety in neonates for transfusion of platelets and plasma prepared with amotosalen photochemical pathogen inactivation treatment by a 1-month intravenous toxicity study in neonatal rats

21 January 2018

1 reference

Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trials

21 January 2018

1 reference

Determination of acute lung injury after repeated platelet transfusions

21 January 2018

1 reference

Quantifying losses to the donated blood supply due to donor deferral and miscollection

21 January 2018

1 reference

The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model

21 January 2018

1 reference

Inter-strand photoproducts are produced in high yield within A-DNA exposed to UVC radiation

21 January 2018

1 reference

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

21 January 2018

1 reference

Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease?

21 January 2018

1 reference

Ultraviolet B light-exposed human platelets mediate acute lung injury in a two-event mouse model of transfusion

21 January 2018

1 reference

The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends.

21 January 2018

1 reference

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

21 January 2018

1 reference

Defining "adequate" pathogen reduction performance for transfused blood components

21 January 2018

1 reference

Pharmacokinetic study of FFP photochemically treated with amotosalen (S-59) and UV light compared to FFP in healthy volunteers anticoagulated with warfarin

21 January 2018

1 reference

West Nile virus infection transmitted by blood transfusion

21 January 2018

1 reference

Removal of prion infectivity by affinity ligand chromatography during OctaplasLG® manufacturing--results from animal bioassay studies.

21 January 2018

1 reference

The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma

21 January 2018

1 reference

The expression of p-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability

21 January 2018

1 reference

Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™

21 January 2018

1 reference

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.

21 January 2018

1 reference

Pathogen inactivation: making decisions about new technologies. Report of a consensus conference

21 January 2018

1 reference

Modeling the risk of an emerging pathogen entering the Canadian blood supply

21 January 2018

1 reference

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

21 January 2018

1 reference

A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion

21 January 2018

1 reference

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

21 January 2018

1 reference

Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections

21 January 2018

1 reference

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

21 January 2018

1 reference

21 January 2018

Reply: To PMID 22664163.

1 reference

Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease

21 January 2018

1 reference

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

Sterilization of platelet concentrates at production scale by irradiation with short-wave ultraviolet light.

21 January 2018

1 reference

Inactivation of pathogens in single units of therapeutic fresh plasma by irradiation with ultraviolet light.

21 January 2018

1 reference

A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light

21 January 2018

1 reference

Anaphylactic shock to fresh‐frozen plasma inactivated with methylene blue

21 January 2018

1 reference

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

21 January 2018

1 reference

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

21 January 2018

1 reference

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.

21 January 2018

1 reference

Clinical studies with solvent detergent-treated products

21 January 2018

1 reference

Pathogen inactivation techniques

21 January 2018

1 reference

Cost-effectiveness of transfusing virus-inactivated plasma instead of standard plasma

21 January 2018

1 reference

Properties of pathogen-inactivated plasma components

21 January 2018

1 reference

Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion

21 January 2018

1 reference

Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.

21 January 2018

1 reference

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

21 January 2018

1 reference

Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma.

21 January 2018

1 reference

Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study.

21 January 2018

1 reference

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

21 January 2018

1 reference

Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction

21 January 2018

1 reference

Methylene blue-treated plasma: an increased allergy risk?

21 January 2018

1 reference

UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma

21 January 2018

1 reference

Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components

21 January 2018

1 reference

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

21 January 2018

1 reference

Dose of prophylactic platelet transfusions and prevention of hemorrhage

21 January 2018

1 reference

Recovery and life span of 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light

21 January 2018

1 reference

Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial

21 January 2018

1 reference

Economics of pathogen inactivation technology for platelet concentrates in Japan

21 January 2018

1 reference

Spore-forming organisms in platelet concentrates: a challenge in transfusion bacterial safety.

21 January 2018

1 reference

Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico

21 January 2018

1 reference

Meta‐analysis of the randomized controlled trials of the hemostatic efficacy and capacity of pathogen‐reduced platelets

21 January 2018

1 reference

Meta-analysis of the studies of bleeding complications of platelets pathogen-reduced with the Intercept system

21 January 2018

1 reference

21 January 2018

1 reference

Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

21 January 2018

1 reference

Proceedings of a Consensus Conference: pathogen inactivation-making decisions about new technologies

21 January 2018

1 reference

A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia

21 January 2018

1 reference

A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation.

21 January 2018

1 reference

Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma

21 January 2018

1 reference

Activation of platelet protein kinase C by ultraviolet light B mediates platelet transfusion-related acute lung injury in a two-event animal model

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12403

1 reference

29 August 2017

1 reference